Prelude Capital Management’s Agios Pharmaceuticals AGIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-21,000
| Closed | -$933K | – | 1062 |
|
|
2024
Q3 | $933K | Buy |
+21,000
| New | +$933K | 0.06% | 353 |
|
|
2024
Q2 | – | Sell |
-15,056
| Closed | -$440K | – | 1098 |
|
|
2024
Q1 | $440K | Buy |
+15,056
| New | +$440K | 0.02% | 612 |
|
|
2020
Q4 | – | Sell |
-1,281
| Closed | -$45K | – | 760 |
|
|
2020
Q3 | $45K | Sell |
1,281
-2,804
| -69% | -$98.5K | ﹤0.01% | 877 |
|
|
2020
Q2 | $218K | Buy |
+4,085
| New | +$218K | 0.01% | 482 |
|
|
2019
Q2 | – | Sell |
-140
| Closed | -$9K | – | 1208 |
|
|
2019
Q1 | $9K | Buy |
+140
| New | +$9K | ﹤0.01% | 1075 |
|
|
2018
Q4 | – | Sell |
-6,701
| Closed | -$517K | – | 1362 |
|
|
2018
Q3 | $517K | Buy |
6,701
+1,400
| +26% | +$108K | 0.03% | 332 |
|
|
2018
Q2 | $447K | Buy |
5,301
+5,152
| +3,458% | +$434K | 0.03% | 437 |
|
|
2018
Q1 | $12K | Buy |
+149
| New | +$12K | ﹤0.01% | 1167 |
|
|
2017
Q4 | – | Sell |
-4,215
| Closed | -$281K | – | 1188 |
|
|
2017
Q3 | $281K | Buy |
4,215
+739
| +21% | +$49.3K | 0.03% | 483 |
|
|
2017
Q2 | $179K | Buy |
+3,476
| New | +$179K | 0.02% | 548 |
|
|
2015
Q1 | – | Sell |
-3,013
| Closed | -$338K | – | 1825 |
|
|
2014
Q4 | $338K | Buy |
+3,013
| New | +$338K | 0.05% | 418 |
|